Federal Register - August 4, 2021

Versión en texto ¿Qué es?Dateas es un sitio independiente no afiliado a entidades gubernamentales. La fuente de los documentos PDF aquí publicados es la entidad gubernamental indicada en cada uno de ellos. Las versiones en texto son transcripciones no oficiales que realizamos para facilitar el acceso y la búsqueda de información, pero pueden contener errores o no estar completas.

Fuente: Federal Register

Federal Register / Vol. 86, No. 147 / Wednesday, August 4, 2021 / Rules and Regulations
lotter on DSK11XQN23PROD with RULES5

which affects FY 2023 payment determination. Data submitted during CY 2022 covers discharges that occur during CY 2021.
After review of the public comments we received, we are finalizing our proposal to allow voluntary patientlevel data reporting for these chartabstracted measures for the FY 2023
payment determination and then to require patient-level data reporting for the FY 2024 payment determination and subsequent years as proposed.
3. Considerations for Data Validation Pilot As discussed in section IV.J.4 and in the FY 2019 IPF PPS final rule, we are concerned about the limitations of aggregate data submission 83 FR
28607. One such concern was that the ability to detect error is lower for aggregate measure data reporting than for patient-level data reporting that is, data regarding each patient included in a measure and whether the patient was included in the numerator and denominator of the measure. In the FY
2022 IPF PPS proposed rule, we noted that if we finalize our proposal to adopt patient-level data requirements, we would be able to adopt a data validation policy for the IPFQR Program in the future 86 FR 19515. We believe that it would be appropriate to develop such a policy incrementally through adoption of a data validation pilot prior to national implementation of data validation within the IPFQR Program.
We sought public input on elements of a potential data validation pilot, for example, the number of measures to validate, number of participating facilities, whether the pilot should be mandatory or voluntary, potential thresholds for determining measure accuracy, or any other policies that commenters believe would be appropriate to include in a data validation pilot or eventual data validation policy.
We received the following comments in response to our request.
Comment: Many commenters supported the concept of data validation but recommended that CMS ensure a stable and successful patient-level reporting process prior to developing a data validation plan.
One commenter recommended using two measures and 200 hospitals to pilot data validation.
Some commenters did not support eventual adoption of validation for the IPFQR program because of the belief that data validation would be burdensome. One commenter observed data validation is only necessary in payfor-performance programs.

VerDate Sep<11>2014

21:11 Aug 03, 2021

Jkt 253001

Response: We thank these commenters for this input and will take it into consideration if we develop a data validation program for the IPFQR
Program.
4. Reporting Requirements for the FY
2022 Payment Determination and Subsequent Years We refer readers to the FY 2013 IPPS/
LTCH PPS final rule 77 FR 53656
through 53657, the FY 2014 IPPS/LTCH
PPS final rule 78 FR 50900 through 50901, and the FY 2015 IPF PPS final rule 79 FR 45976 through 45977 for our previously finalized reporting requirements. We did not propose any changes to these policies.
5. Quality Measure Sampling Requirements We refer readers to the FY 2013 IPPS/
LTCH PPS final rule 77 FR 53657
through 53658, the FY 2014 IPPS/LTCH
PPS final rule 78 FR 50901 through 50902, the FY 2016 IPF PPS final rule 80 FR 46717 through 46719, and the FY 2019 IPF PPS final rule 83 FR 38607
through 38608 for discussions of our previously finalized sampling policies.
In the FY 2022 IPF PPS proposed rule, we noted that neither the measure we proposed to remove FUHNQF 0576
nor the measure we proposed to adopt FAPH if we remove the FUHNQF
0576 are affected by our sampling policies because these are both calculated by CMS using Medicare Feefor-Service claims and, therefore, apply to all Medicare patients in the denominator 86 FR 19515.
Furthermore, the denominator of the COVID19 Healthcare Personnel Vaccination measure we are adopting in this final rule is all healthcare personnel, and therefore, this measure is not eligible for sampling. We did not propose any changes to these policies.
6. Non-Measure Data Collection We refer readers to the FY 2015 IPF
PPS final rule 79 FR 45973, the FY
2016 IPF PPS final rule 80 FR 46717, and the FY 2019 IPF PPS final rule 83
FR 38608 for our previously finalized non-measure data collection policies.
We did not propose any changes to these policies.
7. Data Accuracy and Completeness Acknowledgement DACA
Requirements We refer readers to the FY 2013 IPPS/
LTCH PPS final rule 77 FR 53658 for our previously finalized DACA
requirements. We did not propose any changes to these policies.

PO 00000

Frm 00055

Fmt 4701

Sfmt 4700

42661

K. Reconsideration and Appeals Procedures We refer readers to 42 CFR 412.434
for the IPFQR Programs reconsideration and appeals procedures. We did not propose any changes to these policies.
L. Extraordinary Circumstances Exceptions ECE Policy We refer readers to the FY 2013 IPPS/
LTCH PPS final rule 77 FR 53659
through 53660, the FY 2014 IPPS/LTCH
PPS final rule 78 FR 50903, the FY
2015 IPF PPS final rule 79 FR 45978, and the FY 2018 IPPS/LTCH PPS final rule 82 FR 38473 through 38474 for our previously finalized ECE policies.
We did not propose any changes to these policies.
V. Collection of Information Requirements Under the Paperwork Reduction Act of 1995 PRA 44 U.S.C. 3501 et seq., we are required to provide 60-day notice in the Federal Register and solicit public comment before a collection of information as defined under 5 CFR
1320.3c of the PRAs implementing regulations requirement is submitted to the Office of Management and Budget OMB for review and approval. In order to fairly evaluate whether an information collection should be approved by OMB, section 3506c2A
of the PRA requires that we solicit comment on the following issues:
The need for the information collection and its usefulness in carrying out the proper functions of our agency.
The accuracy of our estimate of the information collection burden.
The quality, utility, and clarity of the information to be collected.
Recommendations to minimize the information collection burden on the affected public, including automated collection techniques.
In the FY 2022 IPF PPS proposed rule 86 FR 19480 we solicited public comment on each of the section 3506c2A-required issues for the following information collection requirements ICRs. As indicated in section V.2.c.1 of this final rule, we received some comments that generally discuss the burden of reporting through NHSN, but not comments specific to our information collection estimates. We have not made any changes from what was proposed.
A. Final ICRs for the IPFQR Program The following final requirement and burden changes will be submitted to OMB for approval under control number 09381171 CMS10432.

E:FRFM04AUR5.SGM

04AUR5

Acerca de esta edición

Federal Register - August 4, 2021

TítuloFederal Register

PaísEstados Unidos de América

Fecha04/08/2021

Nro. de páginas799

Nro. de ediciones7795

Primera edición14/03/1936

Ultima edición15/06/2026

Descargar esta edición

Otras ediciones

<<<Agosto 2021>>>
DLMMJVS
1234567
891011121314
15161718192021
22232425262728
293031